1. A224 COVID-19 INFECTION IN LIVER TRANSPLANT RECIPIENTS: CLINICAL FEATURES, HOSPITALIZATION, AND MORTALITY FROM A CANADIAN MULTICENTRE COHORT. (21st February 2022) Authors: Smith, M K; Chow, J; Huang, R; Omar, M; Ebadi, M; Wong, P; Huard, G; Yoshida, E M; Peretz, D; Brahmania, M; Montano-Loza, A J; Bhanji, R Journal: Journal of the Canadian Association of Gastroenterology Issue: Volume 5(2022)Supplement 1 Page Start: 114 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A55 PREDICTORS OF ENDOSCOPIC HIGH RISK ESOPHAGEAL VARICES IN COMPENSATED CIRRHOSIS: CAN WE AVOID FIBROSCAN?. (1st March 2018) Authors: Huard, G; Hercun, J; Bilodeau, M; Bissonnette, J; Giard, J Journal: Journal of the Canadian Association of Gastroenterology Issue: Volume 1(2018)Supplement 2 Page Start: 88 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A67 ANTIBODY-MEDIATED REJECTION AFTER LIVER TRANSPLANTATION: A CASE SERIES. (15th March 2019) Authors: Vuille-Lessard, É; Bilodeau, M; Willems, B; Marleau, D; Vincent, C; Giard, J; Villeneuve, J; Soucy, G; Nguyen, B; Huard, G Journal: Journal of the Canadian Association of Gastroenterology Issue: Volume 2(2019)Supplement 2 Page Start: 134 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗